Clinical Trial Update: Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China

View source ↗

Summary

This clinical trial update reviews treatment patterns and outcomes for lower-risk myelodysplastic syndrome patients treated with luspatercept in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (Reblozyl) (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myelodysplastic Syndromes | Status: ACTIVE_NOT_RECRUITING